-
Mashup Score: 4
During the Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®, Dr. Mustafa Hyder from the National Cancer Institute presented the results of…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 23Insights on Eltrombopag With Tommy Alfaro Moya at the Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® - 2 month(s) ago
Dr. Shernan Holtan speaks with Tommy Alfaro Moya at the the Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®, who answers the question: Does…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11GVHD Insights from Two-time Transplant Recipient, Becky Dame of The Leukemia and Lymphoma Society - 2 month(s) ago
Drs. Jennifer Holter, MD, and Taha Al-Juhaishi, MD interview Becky Dame of The Leukemia and Lymphoma Society (LLS). Becky is a two-time transplant recipient and has personally battled GVHD….
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14Inspiring the Next Generation at the Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® - 2 month(s) ago
Dr. Shernan Holtan speaks with Dr. Bipin N. Savani on the impact of inspiring the next generation at the Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT® and…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13Tandem 2024 Reflections: Late Effects and Survivorship Post BMT: Moving from Description to Prevention and Intervention - 2 month(s) ago
What stood out to you as the most crucial points discussed in the pre-transplant strategies to optimize the long-term health of the survivor session? The level of sarcopenia provides…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6A Conversation with Mike Niles: Author ‘Hard Graft: Our Fight Against Killer Blood’ - 3 month(s) ago
In this latest episode of ASTCT Talks, Rachel Schollmeier and NMDP’s Samantha Watters host author Mike Niles, delving into the captivating history of the Anthony Nolan bone marrow transplant…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Autologous HSCT outcomes in patients with MM and renal insufficiency - 3 month(s) ago
Garderet L, Ouldjeriouat H, Bekadja M-A, et al. Low Non-Relapse Mortality and Good Haematological and Renal Responses After Autologous Haematopoietic Stem Cell Transplantation in Multiple Myeloma…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Comparison of Seq, MAC, and RIC for patients with higher risk MDS - 3 month(s) ago
Potter V, Gras L, Koster L, et al. Sequential vs Myeloblative vs Reduced Intensity Conditioning for Patients With Myelodysplastic Syndromes With an Excess of Blasts at Time of Allogeneic…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Spatial Transcriptomics Reveals Distinct Tissue Niches Linked with Steroid Responsiveness in Acute Gastrointestinal GVHD - 3 month(s) ago
A study recently published in the journal Blood explored distinct spatial gene expression patterns in cellular compartments of lower gastrointestinal (GI) acute graft-versus-host disease (aGVHD)…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia - 4 month(s) ago
A phase 1 clinical trial, published in the journal Blood Advances, has found the optimal dosing schedule with a tolerable safety profile in patients with relapse/refractory (R/R) acute myeloid…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet
During #Tandem24, Dr. @mustafahydermd from @theNCI presented results from a study on intermediate-dose PTCy in #BMT for older patients. Dr. Andrés Gómez De León details insights from the session on Nucleus: https://t.co/eUUHfB206o